MRP 68.04/-STRIP

Composition

Each uncoated sustained release tablet contains: Metformin Hydrochloride IP 1000 mg. Excipients q.s.

Doses

As Directed by Physician

Description

Treatment of type 2 diabetes mellitus in adults, particularly in overweight patients, when dietary management and exercise alone does not result in adequate glycaemic control. Metformin prolonged-release tablets may be used as monotherapy or in combination with other oral antidiabetic agents, or with insulin.

Formulation

Tablet